Stroke Diagnostic and Therapeutic Market (By Type: Diagnostics (Magnetic Resonance Imaging (MRI), Computed Tomography Scan (CT scan), Electrocardiography, Carotid Ultrasound, Cerebral Angiography, and Others) and Therapeutics (Tissue Plasminogen Activator, Antiplatelet, Antihypertensive, and Anticoagulant); By Application: Haemorrhagic Stroke and Ischemic Stroke) - Global Industry Analysis, Market Size, Share, Trends, Growth, Regional Outlook, and Forecasts 2023-2032
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
5.1. Covid-19: stroke diagnostic and therapeutic Industry Impact
5.2. stroke diagnostic and therapeutic Business Impact Assessment: Covid-19
5.2.1. Services Challenges/Disruption
5.2.2. Market Trends and stroke diagnostic and therapeutic Opportunities in the COVID-19 Landscape for Major Markets
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for stroke diagnostic and Therapeutic Market Players to deal with Covid-19 Pandemic Scenario
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.1.1.1. Increasing number of patients at risk of developing stroke
6.1.1.1.2. Increasing patient awareness
6.1.1.1.3. Increased health care expenditure
6.1.2. Market Restraints
6.1.2.1. High cost of treatment and unfavorable reimbursement scenario
6.1.3. Market Opportunities
6.1.3.1. Growing ongoing research & development in the healthcare sector technologies and emerging markets
7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. stroke diagnostic and Therapeutic Market Revenue by Market Players
7.1.1.2. stroke diagnostic and Therapeutic Market Revenue Market Share by Market Players
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio Expansion, Geographic Expansion, Product Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Market Players Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of End-users
8.1. stroke diagnostic and Therapeutic Market, by Type, 2023-2032
8.1.1. Diagnostic
8.1.1.1. Market Revenue and Forecast (2021-2032)
8.1.2. Therapeutics
8.1.2.1. Market Revenue and Forecast (2021-2032)
9.1. stroke diagnostic and therapeutic Market, by Application, 2021-2032
9.1.1. Haemorrhagic Stroke
9.1.1.1. Market Revenue and Forecast (2021-2032)
9.1.2. Ischemic Stroke
9.1.2.1. Market Revenue and Forecast (2021-2032)
10.1. North America
10.1.1. Market Revenue Forecast by Type (2021-2032)
10.1.2. Market Revenue Forecast by Application(2021-2032)
10.1.3. U.S
10.1.3.1. Market Revenue Forecast (2021-2032)
10.1.4. Canada
10.1.4.1. Market Revenue Forecast (2021-2032)
10.2. Europe
10.2.1. Market Revenue Forecast by Type (2021-2032)
10.2.2. Market Revenue Forecast by Application (2021-2032)
10.2.3. UK
10.2.3.1. Market Revenue Forecast (2021-2032)
10.2.4. Germany
10.2.4.1. Market Revenue Forecast (2021-2032)
10.2.5. France
10.2.5.1. Market Revenue Forecast (2021-2032)
10.2.6. Rest of EU
10.2.6.1. Market Revenue Forecast (2021-2032)
10.3. Asia Pacific (APAC)
10.3.1. Market Revenue Forecast by Type (2021-2032)
10.3.2. Market Revenue Forecast by Application (2021-2032)
10.3.3. China
10.3.3.1. Market Revenue Forecast (2021-2032)
10.3.4. India
10.3.4.1. Market Revenue Forecast (2021-2032)
10.3.5. Japan
10.3.5.1. Market Revenue Forecast (2021-2032)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue Forecast (2021-2032)
10.4. LATAM
10.4.1. Market Revenue Forecast by Type (2021-2032)
10.4.2. Market Revenue Forecast by Application (2021-2032)
10.4.3. Brazil
10.4.3.1. Market Revenue Forecast (2021-2032)
10.4.4. Rest of LATAM
10.4.4.1. Market Revenue Forecast (2021-2032)
10.5. Middle East and Africa (MEA)
10.5.1. Market Revenue Forecast by Type (2021-2032)
10.5.2. Market Revenue Forecast by Application (2021-2032)
10.5.3. GCC
10.5.3.1. Market Revenue Forecast (2021-2032)
10.5.4. North Africa
10.5.4.1. Market Revenue Forecast (2021-2032)
10.5.5. South Africa
10.5.5.1. Market Revenue Forecast (2021-2032)
10.5.6. Rest of MEA
10.5.6.1. Market Revenue Forecast (2021-2032)
11.1. Boston Scientific Corporation
11.1.1. Company Overview, Business Information, Regional Presence
11.1.2. Product Portfolio Analysis
11.1.2.1. Product Details, Specification, Application
11.1.3. Revenue, Price, and Gross Margin
11.1.4. Recent Developments and Strategies
11.2. Medtronic plc
11.2.1. Company Overview, Business Information, Regional Presence
11.2.2. Product Portfolio Analysis
11.2.2.1. Product Details, Specification, Application
11.2.3. Revenue, Price, and Gross Margin
11.2.4. Recent Developments and Strategies
11.3. Cerebrotech Medical Systems, Inc.
11.3.1. Company Overview, Business Information, Regional Presence
11.3.2. Product Portfolio Analysis
11.3.2.1. Product Details, Specification, Application
11.3.3. Revenue, Price, and Gross Margin
11.3.4. Recent Developments and Strategies
11.4. Cordis Corporation
11.4.1. Company Overview, Business Information, Regional Presence
11.4.2. Product Portfolio Analysis
11.4.2.1. Product Details, Specification, Application
11.4.3. Revenue, Price, and Gross Margin
11.4.4. Recent Developments and Strategies
11.5. Neural Analytics
11.5.1. Company Overview, Business Information, Regional Presence
11.5.2. Product Portfolio Analysis
11.5.2.1. Product Details, Specification, Application
11.5.3. Revenue, Price, and Gross Margin
11.5.4. Recent Developments and Strategies
11.6. Koninklijke Philips N.V.
11.6.1. Company Overview, Business Information, Regional Presence
11.6.2. Product Portfolio Analysis
11.6.2.1. Product Details, Specification, Application
11.6.3. Revenue, Price, and Gross Margin
11.6.4. Recent Developments and Strategies
11.7. Medfield Diagnostics
11.7.1. Company Overview, Business Information, Regional Presence
11.7.2. Product Portfolio Analysis
11.7.2.1. Product Details, Specification, Application
11.7.3. Revenue, Price, and Gross Margin
11.7.4. Recent Developments and Strategies
11.8. GE Healthcare
11.8.1. Company Overview, Business Information, Regional Presence
11.8.2. Product Portfolio Analysis
11.8.2.1. Product Details, Specification, Application
11.8.3. Revenue, Price, and Gross Margin
11.8.4. Recent Developments and Strategies
11.9. Samsung Neurologica
11.9.1. Company Overview, Business Information, Regional Presence
11.9.2. Product Portfolio Analysis
11.9.2.1. Product Details, Specification, Application
11.9.3. Revenue, Price, and Gross Margin
11.9.4. Recent Developments and Strategies
11.10. Siemens AG
11.10.1. Company Overview, Business Information, Regional Presence
11.10.2. Product Portfolio Analysis
11.10.2.1. Product Details, Specification, Application
11.10.3. Revenue, Price, and Gross Margin
11.10.4. Recent Developments and Strategies
11.11. NIRX
11.11.1. Company Overview, Business Information, Regional Presence
11.11.2. Product Portfolio Analysis
11.11.2.1. Product Details, Specification, Application
11.11.3. Revenue, Price, and Gross Margin
11.11.4. Recent Developments and Strategies
11.12. Gowerlabs
11.12.1. Company Overview, Business Information, Regional Presence
11.12.2. Product Portfolio Analysis
11.12.2.1. Product Details, Specification, Application
11.12.3. Revenue, Price, and Gross Margin
11.12.4. Recent Developments and Strategies
11.13. Stryker Corporation
11.13.1. Company Overview, Business Information, Regional Presence
11.13.2. Product Portfolio Analysis
11.13.2.1. Product Details, Specification, Application
11.13.3. Revenue, Price, and Gross Margin
11.13.4. Recent Developments and Strategies
11.14. Genentech Inc.
11.14.1. Company Overview, Business Information, Regional Presence
11.14.2. Product Portfolio Analysis
11.14.2.1. Product Details, Specification, Application
11.14.3. Revenue, Price, and Gross Margin
11.14.4. Recent Developments and Strategies
11.15. Merck & Co., Inc.
11.15.1. Company Overview, Business Information, Regional Presence
11.15.2. Product Portfolio Analysis
11.15.2.1. Product Details, Specification, Application
11.15.3. Revenue, Price, and Gross Margin
11.15.4. Recent Developments and Strategies
11.16. Hyperfine MRI
11.16.1. Company Overview, Business Information, Regional Presence
11.16.2. Product Portfolio Analysis
11.16.2.1. Product Details, Specification, Application
11.16.3. Revenue, Price, and Gross Margin
11.16.4. Recent Developments and Strategies
11.17. Abbott Laboratories
11.17.1. Company Overview, Business Information, Regional Presence
11.17.2. Product Portfolio Analysis
11.17.2.1. Product Details, Specification, Application
11.17.3. Revenue, Price, and Gross Margin
11.17.4. Recent Developments and Strategies
12.1. About Us
12.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample